Valuence Merger Corp. I, a blank check company incorporated in the Cayman Islands, has released its Form 10-Q report for the third quarter of 2023. The company, which focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, provided key financial and operational updates in its latest filing.
Financial Highlights
- Net Income: $629,766 for the three months ended September 30, 2023, reflecting interest earned on marketable securities held in trust account of $865,387, offset by general and administrative expenses of $235,620.
- Net Income: $3,990,907 for the nine months ended September 30, 2023, reflecting interest earned on marketable securities held in trust account of $5,258,993, offset by general and administrative expenses of $1,268,085.
- Net Income (Loss) Per Share, Class A ordinary shares: $0.05 for the three months ended September 30, 2023.
- Net Income (Loss) Per Share, Class A ordinary shares: $0.19 for the nine months ended September 30, 2023.
- Net Income (Loss) Per Share, Class B ordinary shares: $0.05 for the three months ended September 30, 2023.
- Net Income (Loss) Per Share, Class B ordinary shares: $0.19 for the nine months ended September 30, 2023.
Business Highlights
- Company Overview: Valuence Merger Corp. I is a blank check company incorporated in the Cayman Islands, focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
- Business Combination Focus: The company intends to concentrate its efforts on identifying a potential business combination partner based in Asia (excluding China, Hong Kong, and Macau) that is developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology.
- Operational Status: As of September 30, 2023, the company had not commenced any operations. All activities to date have been related to the company's formation, the initial public offering, and identifying a target company for a business combination.
- Future Outlook: The company has until December 3, 2023, or March 3, 2025, if extended, to consummate a business combination. Management is actively pursuing potential business combination targets and is using available funds for due diligence and other related activities.
- Extraordinary General Meeting Outcome: On May 25, 2023, shareholders approved an extension of the date by which the company must consummate a business combination to September 3, 2023, with the option to extend further in one-month increments up to March 3, 2025.
- Convertible Promissory Notes: The company issued promissory notes to its sponsor and an affiliate for working capital requirements and expenses related to the business combination. These notes are convertible into warrants under certain conditions.
SEC Filing: